EUVIMEDFaigh amach EUVIMED
Open access · CC BY 4.0

Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution Use

Jennifer M Jones iD, Fatima Aldarweesh iD, Nicole Aqui, Aleh Bobr iD, Patricia Brunker iD, Mischa L Covington iD, Juliana Guarente iD, Robert Hagar, Matthew Karafin, Divjot Singh Lamba iD, Grace Lee iD, Wen Lu iD and 16 more

Journal of Clinical Apheresis · 2026-06 · 41 (3)

DOI: 10.1002/jca.70146 ↗

At a glance

Journal article in Journal of Clinical Apheresis, published online on 2026-06-18. Written by Jennifer M Jones and 27 co-authors. Institution: Department of Pathology and Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA. Major MEDLINE topics: Anemia, Sickle Cell, Erythrocyte Transfusion, Hemodilution, Blood Component Removal. 34 references. The full text is freely available (open access, CC BY 4.0).

AchoimreSubjectsSonraí leabharliostaCiteRelated studies

Abstract (original language)

Prior surveys of chronic automated red blood cell exchange (RCE) for patients with sickle cell disease (SCD) have identified considerable procedural variability, especially with the use of isovolemic hemodilution red blood cell exchange (IHD‐RCE). We conducted a survey of chronic RCE practices among American Society for Apheresis (ASFA) members to identify opportunities for practice harmonization and future studies. The ASFA SCD Research Subcommittee developed a 72‐item survey of chronic RCE practices, with a focus on IHD‐RCE. The survey was validated internally and distributed by email to all ASFA members from September 2024 to February 2025. One survey response from each institution was retained for data analysis. Descriptive statistics were performed. Sixty‐two survey responses, including three from international institutions, were retained for analysis. Sixty‐one percent of respondents (38/62) reported using at least one fixed RCE target, with end hematocrit being the most common fixed parameter (40%, 25/62), followed by fraction of cells remaining (31%, 19/62) and hemoglobin S% (27%, 17/62). Most respondents (60%, 37/61) performed IHD‐RCE at their institution, though other details such as the minimum hematocrit, exclusion criteria, and response to adverse effects were variable. Consistent pre‐ and post‐RCE laboratory monitoring practices were reported. Consistent with earlier surveys, procedural variability in chronic RCE practices for patients with SCD is observed. This highlights opportunities to compare outcomes where practice variability exists. Consensus guidelines based on institutional practices with optimal outcomes should be developed.

Subjects

MeSH terms (MEDLINE)

Anemia, Sickle CellErythrocyte TransfusionHemodilutionBlood Component RemovalHumansSurveys and QuestionnairesHematocrit

Author keywords

automated red blood cell exchangepractice variabilitysickle cell diseasesurvey

Authors and institutions

  • Department of Pathology and Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
  • University of Chicago, Chicago, Illinois, USA.
  • Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • University of Nebraska Medical Center, Omaha, Nebraska, USA.
  • Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Brigham and Women's Hospital, Boston, Massachusetts, USA.

ORCID profiles: Jennifer M Jones, Fatima Aldarweesh, Aleh Bobr, Patricia Brunker, Mischa L Covington, Juliana Guarente, Divjot Singh Lamba, Grace Lee, Wen Lu, Ethan A Mack, Chinelo P Onyenekwu, Divya Setya, Yvette C Tanhehco, Angelica Vivero, Nalan Yurtsever, Yan Zheng, Patricia A Shi, Jennifer Webb

Cite

APA

Jones, J. M., Aldarweesh, F., Aqui, N., Bobr, A., Brunker, P., Covington, M. L., Guarente, J., Hagar, R., Karafin, M., Lamba, D. S., Lee, G., Lu, W., Mack, E. A., Muthur, G., Nazli, S., Olaniyan, H., Onyenekwu, C. P., Raval, J. S., Setya, D., …, & Webb, J. (2026). Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution Use. Journal of Clinical Apheresis, 41(3). https://doi.org/10.1002/jca.70146

Vancouver

Jones JM, Aldarweesh F, Aqui N, Bobr A, Brunker P, Covington ML, et al. Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution Use. Journal of Clinical Apheresis. 2026;41(3). doi:10.1002/jca.70146

BibTeX
@article{Jones2026,
  author = {Jones, Jennifer M and Aldarweesh, Fatima and Aqui, Nicole and Bobr, Aleh and Brunker, Patricia and Covington, Mischa L and Guarente, Juliana and Hagar, Robert and Karafin, Matthew and Lamba, Divjot Singh and Lee, Grace and Lu, Wen and Mack, Ethan A and Muthur, Gagan and Nazli, Saadiya and Olaniyan, Halima and Onyenekwu, Chinelo P and Raval, Jay S and Setya, Divya and Tanhehco, Yvette C and Thant, Mamie and Vivero, Angelica and Wu, Yanyun and Wong, Edward C C and Yurtsever, Nalan and Zheng, Yan and Shi, Patricia A and Webb, Jennifer},
  title = {Variation in Chronic Automated Red Cell Exchange Practices for Sickle Cell Disease: Insights Into Isovolemic Hemodilution Use},
  journal = {Journal of Clinical Apheresis},
  year = {2026},
  volume = {41},
  number = {3},
  doi = {10.1002/jca.70146}
}
Start for free →